Neuroprotective effect of ace inhibitors in glutamate - induced neurotoxicity: Rat neuron culture study

Turkish Neurosurgery

Volumn 21, Issue 3, 2011, Pages 367-371

  Sengul, Goksin ^a   Coskun, Suleyman ^a   Cakir, Murteza ^a   Coban, Mustafa Kemal ^a   Saruhan, Fatih ^a   Hacimuftuoglu, Ahmet ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

ACE inhibitors; Glutamate; Neuroprotection; Neurotoxicity

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUTAMIC ACID; NEUROPROTECTIVE AGENT; PERINDOPRIL; RAMIPRIL;

ANIMAL; ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; NERVE CELL; NEWBORN; RAT; SPRAGUE DAWLEY RAT; TOXICITY AND INTOXICATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANIMALS, NEWBORN; CAPTOPRIL; CELL SURVIVAL; CELLS, CULTURED; GLUTAMIC ACID; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; PERINDOPRIL; RAMIPRIL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84855170990     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: 10.5137/1019-5149.JTN.4313-11.0     Document Type: Article

References (32)

1. Araque A, Parpura V, Sanzgiri RP, Haydon PG: Glutamatedependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. Eur J Neurosci 10: 2129-2142, 1998
2. Bagchi D, Prasad R, Das DK: Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem Biophys Res Commun 158: 52-57, 1989
3. Birincioglu M, Aksoy T, Olmez E, Acet A: Protective effect of ACE inhibitors on ischemia-reperfusion-induced arrhythmias in rats: Is this effect related to the free radical scavenging action of these drugs? Free Radic Res 27: 389-396, 1997
4. Chan PH: Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2-14, 2001
5. Chopra M, Scott N, McMurray J, McLay J, Bridges A, Smith WE, Belch JJ: Captopril: A free radical scavenger. Br J Clin Pharmacol 27: 396-399, 1989
6. Cuzzocrea S, Zingarelli B, Gilad E, Hake P, Salzman AL, Szabó C: Protective effect of melatonin in carrageenan-induced models of local inflammation: Relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J Pineal Res 23:106-116, 1997
7. Daikhin, Y, Yudkoff M: Compartmentation of brain glutamate metabolism in neurons and glia. J Nutr 130:1026-1031, 2000
8. Egan TM, Minta JO, Scrimgeour KG, Cooper JD: Captopril-a potential free radical scavenger: Inhibition of PMN NADPH oxidase. Clin Invest Med 11: 351-356, 1988
9. Hirooka K, Shiraga F: Potential role for angiotensinconverting enzyme inhibitors in the treatment of glaucoma. Clin Ophthalmol 1: 217-223, 2007
10. Gepdiremen A, Düzenli S, Hacimüftüoglu A, Bulucu D, Süleyman H: The effects of melatonin in glutamate-induced neurotoxicity of rat cerebellar granular cell culture. Jpn J Pharmacol 84: 467-469, 2000
11. Gepdiremen A, Hacimüftüoglu A, Büyükokuroglu ME, Süleyman H: Nitric oxide donor sodium nitroprusside induces neurotoxicity in cerebellar granular cell culture in rats by an independent mechanism from L-type or dantrolene-sensitive calcium channels. Biol Pharm Bull 25: 1295-1297, 2002
12. Gepdiremen A, Hacimüftüoglu A, Düzenli S, Oztas S, Süleyman H: Effects of salicylic acid in glutamate- and kainic acid-induced neurotoxicity in cerebellar granular cell culture of rats. Pharmacol Res 42: 547-551, 2000
13. Goldschmidt JE, Tallarida RJ: Pharmacological evidence that captopril possesses and endothelium-mediated component of vasodilation: Effect of sulfhydryl groups on endothelium derived relaxing factor. J Pharmacol Exp Ther 257:1136-1145, 1991
14. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF: Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 17: 626-635, 1991
15. Isbir CS, Dogan R, Farsak B, Aydin M: The effect of captopril on membrane bound enzymes in ischemia-reperfusion injury. Cardiovasc Surg 8: 192-197, 2000
16. Kim JS, Yun I, Choi YB, Lee KS, Kim YI: Ramipril protects from free radical induced white matter damage in chronic hypoperfusion in the rat. J Clin Neurosci 15: 174-178, 2008
17. Korfali{dotless} E, Kahveci N: Serebral iskeminin patofizyolojisi. İçinde: Aksoy K, ed. Temel Nöroşirürji, Ankara: Buluş Tasari{dotless}m ve Matbaaci{dotless}li{dotless}k, 2005:384-387
18. Kurosaki R, Muramatsu Y, Kato H, Watanabe Y, Imai Y, Itoyama Y, Araki T: Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice. Eur Neuropsychopharmacol 15:57-67, 2005
19. Leonetti G, Cuspidi C: Choosing the right ACE inhibitor. A guide to selection. Drugs 49: 516-535, 1995
20. Li Q, Zhang J, Loro JF, Pfaffendorf M, van Zwieten PA: Bradykinin B2-receptor-mediated positive chronotropic effect of bradykinin in isolated rat atria. J Cardiovasc Pharmacol 32: 452-456, 1998
21. Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL: Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. J Neurosci Res 81: 865-873, 2005
22. Mira ML, Silva MM, Queiroz MJ, Manso CF: Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Radic Res Commun 19:173-181, 1993
23. Opie LH: Angiotensin: Converting Enzyme Inhibitors: Scientific Basis for Clinical Use. New York: Willey-Liss, 1994
24. Peiró C, Llergo JL, Angulo J, López-Novoa JM, Rodríguez-López A, Rodríguez-Mañas L, Sánchez-Ferrer CF: Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats. Br J Pharmacol 121: 1438-1444, 1997
25. Pi X-J, Chen X: Captopril and ramiprilat protect against free radical injury in isolated working rat heart. J Mol Cell Cardiol 21:1261-1271, 1989
26. Pines A, Fisman EZ: ACE Inhibition with moexipril: A review of potential effects beyond blood pressure control. Am J Cardiovasc Drugs 3:351-360, 2003
27. Ravati A, Junker V, Kouklei M, Ahlemeyer B, Culmsee C, Krieglstein J: Enalapril and moexipril protect from free radicalinduced neuronal damage in vitro and reduce ischemic brain injury in mice and rats. Eur J Pharmacol 373: 21-33, 1999
28. Schulz JB, Henshaw DR, Siwek D, Jenkins BG, Ferrante RJ, Cipolloni PB, Kowall NW, Rosen BR, Beal MF: Involvement of free radicals in excitotoxicity in vivo. J Neurochem 64: 2239-2247, 1995
29. Stokinger HE: Boron. In: Clayton GD, Clayton FE, eds. Patty's industrial hygiene and toxicology. Vol. 2B. Toxicology, 3rd ed. New York, NY: John Wiley & Sons, 1981:2978-3005
30. Yamauchi T, Kashii S, Yasuyoshi H, Zhang S, Honda Y, Akaike A: Mitochondrial ATP-sensitive potassium channel: A novel site for neuroprotection. Invest Ophthalmol Vis Sci 44: 2750-2756, 2003
31. Yasumatsu R, Nakashima T, Masuda M, Ito A, Kuratomi Y, Nakagawa T, Komune S: Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 130:567-573, 2004
32. Yu W, Akishita M, Xi H, Nagai K, Sudoh N, Hasegawa H, Kozaki K, Toba K: Angiotensin converting enzyme inhibitor attenuates oxidative stress-induced endothelial cell apoptosis via p38 MAP kinase inhibition. Clin Chim Acta 364: 328-334, 2006